<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01027429</url>
  </required_header>
  <id_info>
    <org_study_id>SC134GL50124</org_study_id>
    <nct_id>NCT01027429</nct_id>
  </id_info>
  <brief_title>Simplified Antibiotic Therapy for Sepsis in Young Infants</brief_title>
  <acronym>SATT</acronym>
  <official_title>Simplified Antibiotic Regimens for the Management of Sepsis in Young Infants in First-level Facilities: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aga Khan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Save the Children</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>World Health Organization</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>London School of Hygiene and Tropical Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aga Khan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial evaluates primary care clinic-based simplified antibiotic therapy options for
      young infants, 0-59 days old in high neonatal mortality settings in peri-urban Karachi where
      hospital referral is frequently refused by families.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Objective

      To evaluate if out-patient (clinic-based) therapy of young infants with possible serious
      bacterial infection with 7 days of intramuscular procaine penicillin and gentamicin
      (reference therapy) is equivalent to:

        -  (1) injectable gentamicin once daily and oral amoxicillin twice daily for seven days;

        -  (2) injectable penicillin and gentamicin once daily for two days followed by oral
           amoxicillin twice daily for five days; and

      Hypothesis

      The proportion of babies who fail therapy at (or before 7) days will be 10% in each group. A
      5% or less difference in failure rates will be considered equivalent.

      Study Design

      This will be a randomized, three arm, open-label equivalence trial among young infants, 0-59
      days of age who are diagnosed as having possible serious bacterial infection in one of the
      Karachi field clinics, and whose families refuse facilitated hospital referral, and the
      infants meet other specified inclusion criteria.

      Eligible young infants will be recruited from among those referred to the clinics by trained
      community health workers as having clinical signs predictive of possible serious illness
      during regular home visits in the surveillance area, or those presenting directly to the
      clinics from the areas under pregnancy and newborn surveillance. A diagnosis of possible
      sepsis will be made by clinicians if specified clinical criteria are met.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment failure</measure>
    <time_frame>within 7 days of enrolment</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">2543</enrollment>
  <condition>Neonatal Sepsis</condition>
  <condition>Sepsis</condition>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>procaine penicillin and gentamicin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Procaine penicillin, 50,000 IU/kg by intramuscular injection plus gentamicin, 5 mg/kg intramuscular injection, both given once daily for 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Amoxicillin and gentamicin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral amoxicillin (80-90 mg/kg) divided twice daily and intramuscular gentamicin, 5 mg/kg once daily, both given for 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>procaine penicillin, gentamicin, and amoxicillin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>procaine penicillin, 50,000 IU/kg once daily intramuscular injection plus gentamicin 5 mg/kg once daily intramuscular injection for 2 days, followed by 5 days of oral amoxicillin, 80-90 mg/kg divided in two doses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>procaine penicillin and gentamicin</intervention_name>
    <description>procaine penicillin 50,000 units/kg by intramuscular injection once daily for 7 days; gentamicin, 5 mg/kg once daily by intramuscular injection for 7 days</description>
    <arm_group_label>procaine penicillin and gentamicin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>amoxicillin and gentamicin</intervention_name>
    <description>oral amoxicillin 80-90 mg/kg divided in two doses for 7 days intramuscular gentamicin, 5 mg/kg once daily for 7 days</description>
    <arm_group_label>Amoxicillin and gentamicin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>procaine penicillin, gentamicin, amoxicillin</intervention_name>
    <description>procaine penicillin, 50,000 IU/kg once daily intramuscular injection plus gentamicin 5 mg/kg once daily intramuscular injection for 2 days, followed by 5 days of oral amoxicillin, 80-90 mg/kg divided in two doses.</description>
    <arm_group_label>procaine penicillin and gentamicin</arm_group_label>
    <arm_group_label>Amoxicillin and gentamicin</arm_group_label>
    <arm_group_label>procaine penicillin, gentamicin, and amoxicillin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inclusion Criteria

               -  Infants 0-59 days old who are residents of catchment population of the study
                  hospitals or clinics

               -  One or more of the following five signs: severe chest in-drawing, axillary
                  temperature &gt;38.0C or &lt;35.50 C, movement only when stimulated, and history of
                  feeding problems (confirmed by poor suck on feeding assessment)

               -  Family refuses recommended hospitalization or hospitalization otherwise not
                  feasible

               -  Informed consent by a legal guardian.

          -  Exclusion Criteria:

        Very severe infection/disease characterized by presence of any of the following signs
        (unconscious, convulsions, unable to feed, apnea, unable to cry, cyanosis, bulging
        fontanel, prolonged capillary refill, major congenital malformations, major bleeding,
        surgical conditions needing hospital referral, persistent vomiting defined as vomiting
        following three attempts to feed the baby within Â½ hour)

          -  Very low birth weight: weight &lt;1500

          -  Hospitalization for illness in the last two weeks

          -  Previous inclusion in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>59 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shiyam S Sunder, MBBS</last_name>
    <role>Study Director</role>
    <affiliation>The Aga Khan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ali Akber Shah Goth</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <zip>74800</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2009</study_first_submitted>
  <study_first_submitted_qc>December 7, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2009</study_first_posted>
  <last_update_submitted>June 26, 2015</last_update_submitted>
  <last_update_submitted_qc>June 26, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aga Khan University</investigator_affiliation>
    <investigator_full_name>Anita Kaniz Mehdi Zaidi</investigator_full_name>
    <investigator_title>Professor and Chair, Department of Paediatrics and Child Health</investigator_title>
  </responsible_party>
  <keyword>infant</keyword>
  <keyword>newborn</keyword>
  <keyword>sepsis</keyword>
  <keyword>infection</keyword>
  <keyword>community</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Neonatal Sepsis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Gentamicins</mesh_term>
    <mesh_term>Penicillins</mesh_term>
    <mesh_term>Penicillin G Procaine</mesh_term>
    <mesh_term>Penicillin G</mesh_term>
    <mesh_term>Penicillin G Benzathine</mesh_term>
    <mesh_term>Procaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

